Navigation Links
Global Idiopathic Pulmonary Fibrosis Drugs Price Strategies Report 2016: How the Price Advanced from 2012 and Forecast to 2021 - Research and Markets
Date:11/18/2016

DUBLIN, Nov 18, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Idiopathic Pulmonary Fibrosis Drugs Price Analysis and Strategies - 2016" report to their offering.

Idiopathic Pulmonary Fibrosis Drugs Price Analysis and Strategies 2016, provides drug pricing data and benchmarks in the global Idiopathic Pulmonary Fibrosis market.

The research answers the following questions:

  • What are the key drugs marketed for Idiopathic Pulmonary Fibrosis and their clinical attributes? How are they positioned in the Global Idiopathic Pulmonary Fibrosis market?
  • What are the unit prices and annual treatment cost for Idiopathic Pulmonary Fibrosis therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
  • What are the unmet needs in the global Idiopathic Pulmonary Fibrosis drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Idiopathic Pulmonary Fibrosis?

Research Scope:

  • Treatment Options - Identify key drugs marketed and prescribed for Idiopathic Pulmonary Fibrosis including trade name, molecule name, and company
  • Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Idiopathic Pulmonary Fibrosis
  • Market Positioning - Identify how drugs are clinically and commercially positioned in the global Idiopathic Pulmonary Fibrosis market
  • Idiopathic Pulmonary Fibrosis Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed
  • Find out how the price advanced from 2012 and forecast to 2021
  • Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape
  • Idiopathic Pulmonary Fibrosis New Drug Pricing - Identify the effective pricing strategy for a new drug launch

Key Topics Covered:

1. Treatment Options

2. Drugs Clinical Attributes

3. Drugs Market Positioning

4. Drugs Price Analysis

5. Drugs Price Benchmarks

6. Drug Pricing & Reimbursement Landscape

7. Drugs Price Forecast

8. Market Unmet Needs

9. New Drug Pricing

For more information about this report visit http://www.researchandmarkets.com/research/6mxwv7/idiopathic

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-idiopathic-pulmonary-fibrosis-drugs-price-strategies-report-2016-how-the-price-advanced-from-2012-and-forecast-to-2021---research-and-markets-300365739.html


'/>"/>
SOURCE Research and Markets
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
3. The Rockley Group and Content Rules Ink Deal to Extend Global Reach
4. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
5. Amgen To Present At The UBS Global Life Sciences Conference
6. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
8. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
9. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
10. TRACE Releases 2012 Global Enforcement Report
11. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2019)... ... 16, 2019 , ... Benchworks is proud to announce that ... the healthcare industry’s most influential people. PM360, the premier information resource for marketing ... to the 2019 PM360 ELITE 100 in the Disruptor category. Now in its ...
(Date:5/16/2019)... ... 16, 2019 , ... Remedy Health Media (Remedy), ... the acquisition of Vertical Health , a premium publisher serving patients and ... This acquisition makes Remedy the first—and only—health media company to house multiple chronic ...
(Date:5/16/2019)... ... 2019 , ... After raising more than $133,000 on Kickstarter, more ... continues on Indiegogo InDemand. , “We created MODL as the only bottle ... be the first to enjoy all the features it has to offer,” said MODL ...
Breaking Medicine Technology:
(Date:5/21/2019)... Md. and GAITHERSBURG, Md. (PRWEB) , ... May 21, 2019 , ... ... from measles with a safe, proven and effective solution: vaccination. , Between January 1, ... 764 cases of measles across 23 states. Worryingly, this number includes a 60 case ...
(Date:5/21/2019)... ... May 21, 2019 , ... ... of collaborative robots for industrial applications, announced today it will be launching demonstration ... 2 (DIP2) in Dubai, UAE, and in Buseck, Germany. These demonstration centres will ...
(Date:5/21/2019)... ... May 21, 2019 , ... Pool and Spa News, ... system a Top 50 Product of 2019, recognizing market’s demand for the best, easiest ... was chosen from reader responses in Pool and Spa News’ 2019 New Products ...
(Date:5/21/2019)... ... May 21, 2019 , ... Peoria Ear, Nose ... County, says they are embracing a people-plus-technology strategy to help service a rapidly-growing ... As part of this strategy, they have partnered with Dallas-based Simple Interact ...
(Date:5/16/2019)... ... 2019 , ... Wambi, a leading workforce engagement company driving ... will be joining the company as Chief Clinical Officer. , In this role, ... features that create value for Wambi’s clients, nurse leaders and their teams. Dr. ...
Breaking Medicine News(10 mins):